Načítá se...
Combination ACE Inhibitor and Angiotensin Receptor Blocker Therapy—Future Considerations
Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers are regularly prescribed for the management of hypertension. Each of these drug classes has also been shown to provide survival benefits for patients with heart failure, proteinuric chronic kidney disease, and/or a high cardi...
Uloženo v:
| Vydáno v: | J Clin Hypertens (Greenwich) |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Le Jacq
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109912/ https://ncbi.nlm.nih.gov/pubmed/17215664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2007.6359.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|